Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)
Clinical trial NCT02577016 · COMPLETED
Trial details
- NCT number
- NCT02577016
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-05
- Primary completion
- 2016-11-18
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.